Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
BMJ Open|May 22, 2024
Efficacy and safety of pentosan polysulfate sodium in people with symptomatic knee osteoarthritis and dyslipidaemia: protocol of the MaRVeL trialMd Abu Bakar Siddiq, Xiaoqian Liu, Tatyana Fedorova, et al.
European Journal of Endocrinology|July 5, 2023
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trialKristy P Robledo, Ian C Marschner, David J Handelsman, et al.
JAMA Dermatology|December 3, 2025
Mobile Dermatoscope Type in Patient-Performed Teledermoscopy: A Study Within A TrialDeonna M Ackermann, Ellie Medcalf, Robin M Turner, et al.
Osteoarthritis and Cartilage|June 22, 2026
Effect of an Oral Complementary Medicine Combination for Symptomatic Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled TrialShiwen Yuan, Xiaoqian Liu, Karen Bracken, et al.
Trials|June 21, 2019
Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategiesKaren Bracken, Wendy Hague, Anthony Keech, et al.
European Journal of Endocrinology|January 10, 2022
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injectionsDavid J Handelsman, Reena Desai, Ann J Conway, et al.
JMIR Human Factors|July 15, 2026
Feasibility of the "OA Coach" Mobile App to Support Individuals with Osteoarthritis: Development and Usability TestingVicky Duong, Naomi Bloul, Jocelyn Bowden, et al.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2025
Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) TrialGary A Wittert, Kristy P Robledo, David J Handelsman, et al.
Clinical Trials (London, England)|October 5, 2019
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trialKaren Bracken, Anthony Keech, Wendy Hague, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trialGary Wittert, Evan Atlantis, Carolyn Allan, et al.
Pageof 3